omeprazole has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-five participants were randomised (23 to omeprazole, 22 to placebo), with 40 (20 in each group) having cough monitoring before and after treatment." | 9.30 | Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis. ( Dutta, P; Forbes, R; Forrest, IA; Funston, W; Griffin, SM; Jones, R; Mossop, H; Pearson, J; Ryan, V; Sen, S; Simpson, AJ; Smith, JA; Ward, C, 2019) |
| "Forty-five participants were randomised (23 to omeprazole, 22 to placebo), with 40 (20 in each group) having cough monitoring before and after treatment." | 5.30 | Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis. ( Dutta, P; Forbes, R; Forrest, IA; Funston, W; Griffin, SM; Jones, R; Mossop, H; Pearson, J; Ryan, V; Sen, S; Simpson, AJ; Smith, JA; Ward, C, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, P | 1 |
| Funston, W | 1 |
| Mossop, H | 1 |
| Ryan, V | 1 |
| Jones, R | 1 |
| Forbes, R | 1 |
| Sen, S | 1 |
| Pearson, J | 1 |
| Griffin, SM | 1 |
| Smith, JA | 1 |
| Ward, C | 1 |
| Forrest, IA | 1 |
| Simpson, AJ | 1 |
1 trial available for omeprazole and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Cough; Double-Blind Method; Feasibility Studies; Female; Forced Expi | 2019 |